Colleen Campbell
Showing 1–2 of 2 transcripts.
- Milken Institute1h 1m
Decoding Disease: Can Genetics Unlock New Interventions? | Future of Health Summit 2024
Conor Hale, Colleen Campbell, Lon Cardon, Bernard Kwabi-Addo, Benjamin Neale
Experts highlight that while genomic knowledge has expanded to 12,000 identified variants, translating these discoveries into clinical care remains hindered by insurance barriers, provider literacy gaps, and biased data representation. To overcome these bottlenecks, the field is increasingly leveraging artificial intelligence for tumor heterogeneity analysis and shifting toward deconstructing common diseases into rare, monogenic subsets for targeted therapies. With sequencing costs dropping to roughly $200, stakeholders anticipate widespread population screening programs and systematic variant analysis across human diseases becoming feasible within the next decade.
- Milken Institute54 min
Evolving Opportunities in Capital Markets
Mark Antonacio, Colleen Campbell, Lowell Craft, Soren Reinertsen, Justin Slacky
Mark Antonacio, Colleen Campbell, and four other financial experts convened to analyze credit market risks characterized by a potential leveraged loan bubble, deteriorating covenant quality, and an artificially extended cycle driven by Federal Reserve stimulus. The panelists highlighted a structural divergence where record refinancing volumes mask stable leverage metrics, while regulatory shifts force banks out of middle-market lending and onto non-traditional sectors like energy and infrastructure. Ultimately, the discussion identified liquidity constraints and pension fund underfunding as primary near-term threats, prompting a strategic shift toward consolidation in alternative asset management and increased reliance on private credit vehicles.